Clinical Trial Update: Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating letrozole plus ribociclib versus letrozole plus placebo as neoadjuvant therapy for ER-positive, HER2-negative early breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Ribociclib (ribociclib)

Snippet

Sponsor: Qamar Khan | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-03-11